department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

LIRAGLUTIDE · pharmadog

pharmadog
drugs
LIRAGLUTIDE

drug

patient view →

LIRAGLUTIDE

Preclinicalupdated 2mo ago

by $LEXX Lexaria Bioscience Corp.

Preclinical

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

LIRAGLUTIDE

generic

LIRAGLUTIDE

indication

Diabetes

phase

preclinical

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval110 co-mentions · 55 sources
drugVICTOZA104 co-mentions · 56 sources
drugSaxenda75 co-mentions · 56 sources
companyNovo Nordisk Inc30 co-mentions · 30 sources
companyBiocon Pharma Ltd2 co-mentions · 2 sources
companyFresenius Kabi USA LLC1 co-mentions · 1 sources
tagDrug Shortage1 co-mentions · 1 sources
drugRNS-601 co-mentions · 1 sources

Trials studying LIRAGLUTIDE

phase1Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)recruitingn=75
—Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patientscompletedn=27
phase4A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in Americacompletedn=500
—Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.completedn=300
—Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Koreacompletedn=750
phase3SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesityactive not recruitingn=78
phase4Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Controlrecruitingn=430
N/AThe Evira Study: Additional Support During Anti-Obesity Treatmentnot yet recruitingn=40

more trials →